4//SEC Filing
Song Hong Fang 4
Accession 0002008157-25-000004
CIK 0001991792other
Filed
Sep 3, 8:00 PM ET
Accepted
Sep 4, 5:00 PM ET
Size
12.8 KB
Accession
0002008157-25-000004
Insider Transaction Report
Form 4
Song Hong Fang
Director
Transactions
- Sale
Common Stock
2025-09-03$27.60/sh−69,695$1,923,582→ 2,934,236 total(indirect: By Chaming Jade Limited) - Sale
Common Stock
2025-09-03$28.96/sh−100$2,896→ 2,904,031 total(indirect: By Charming Jade Limited) - Sale
Common Stock
2025-09-03$28.24/sh−30,105$850,165→ 2,904,131 total(indirect: By Charming Jade Limited) - Sale
Common Stock
2025-09-03$28.99/sh−100$2,899→ 2,903,931 total(indirect: By Charming Jade Limited)
Holdings
- 586,982(indirect: By Unique Diamond Investments Limited)
Common Stock
- 613,928
Common Stock
Footnotes (5)
- [F1]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $26.94 to $27.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F2]Charming Jade Limited is a wholly owned subsidiary of ORI Healthcare Fund II, L.P. ORI Capital II Inc. is the general partner of ORI Healthcare Fund II, L.P. and a wholly owned subsidiary of ORI Holding II Inc.
- [F3]Each of ORI Holding II Inc. and ORI Capital Holding Inc. is a wholly owned subsidiary of Healthcare Seed Limited. Ms. Song is the sole owner of Healthcare Seed Limited. As a result of these relationships, each of the foregoing entities and Ms. Song may be deemed to share beneficial ownership over the securities held of record by Unique Diamond Investments Limited and Charming Jade Limited, except to the extent of their pecuniary interests therein.
- [F4]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $27.94 to $28.93, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range.
- [F5]Unique Diamond Investments Limited is a wholly owned subsidiary of ORI Healthcare Fund, L.P. ORI Capital Inc. is the general partner of ORI Healthcare Fund, L.P. and a wholly owned subsidiary of ORI Capital Holding Inc.
Documents
Issuer
CG Oncology, Inc.
CIK 0001991792
Entity typeother
Related Parties
1- filerCIK 0002008157
Filing Metadata
- Form type
- 4
- Filed
- Sep 3, 8:00 PM ET
- Accepted
- Sep 4, 5:00 PM ET
- Size
- 12.8 KB